Get a Free 5ml Mini Now Free 5ml Mini With Every Order of The Mantle
Moumoujus

N-ADAMANTANOYL DOPAMINE.

Insufficient Data / ANTIOXIDANT, SKIN PROTECTING

N-ADAMANTANOYL DOPAMINE, also referred to as Dopamantine, is a synthetic derivative of dopamine. It was initially engineered to enhance dopamine's ability to cross the blood-brain barrier for neurological applications, utilizing its lipophilic adamantane structure. Information regarding its specific utility or mechanism within topical skincare formulations is currently absent.

Summary

Science

Mechanism of Action

While N-ADAMANTANOYL DOPAMINE was designed to facilitate dopamine delivery and may share some pharmacological characteristics with amantadine, its precise mechanism of action when applied to the skin remains entirely undefined. General dopamine functions predominantly as a neuromodulatory molecule and neurotransmitter in the brain, with no established cutaneous roles for this specific derivative.

Research

Clinical Evidence

Low confidence
Effective range N/A
Optimal

N/A

Transparency

Dusting Analysis

Not commonly dusted

There is no available data to suggest N-ADAMANTANOYL DOPAMINE commonly exhibits dusting behavior in cosmetic formulations.

The Formula

Formulation

Solubility
Unknown
Optimal pH N/A
0 7 14

Stability

Based on its parent compound, dopamine, N-ADAMANTANOYL DOPAMINE may be highly sensitive to oxygen and light, potentially leading to rapid discoloration. Dopamine is notably unstable in alkaline conditions, degrading significantly faster than in acidic environments. Its autoxidation is mitigated at acidic pH, with a half-life measured in days at pH below 5.6, contrasting with a rapid disappearance within minutes at pH 7.4. While specific data for the derivative is not available, formulating in an acidic pH range and incorporating stabilizing agents such as ascorbic acid, EDTA, or acetic acid may be beneficial for stability.

Synergies

  • Ascorbic acid
  • EDTA
  • Acetic acid

Conflicts

  • Alkaline pH
  • Oxygen
  • Light

Safety

Safety Profile

CIR Status
Not reviewed
Sensitization risk Unknown

N-ADAMANTANOYL DOPAMINE was developed as an antiparkinsonian drug but was never commercially marketed. There are no specific safety assessments from regulatory bodies such as CIR, SCCS, or FDA pertaining to its use in skincare. It is important to note that Dopamine Hydrochloride, a related compound, is classified with GHS statements indicating it 'Causes skin irritation,' 'Causes serious eye irritation,' and is 'Harmful if swallowed.'

Your Skin

Skin Compatibility

No Normal
No Dry
No Oily
No Sensitive
Irritancy Unknown
Comedogenicity Unknown

Our Assessment

Verdict

Insufficient Data

Due to a complete lack of research regarding its efficacy, safety, and mechanism of action within skincare, the inclusion of N-ADAMANTANOYL DOPAMINE in topical formulations is not currently supported by data.

Related

Similar Ingredients

Finding similar ingredients…